On This Page

Filter

These are the filters currently being used to limit the search results. Click on the
icon to remove the filter.

answering dept short name

Health and Social Care

answer › answering member printed

Seema Kennedy

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are
shown at the top of the list. Click on to remove a sort and or to reverse the current sort order. Click on the icon to remove all the sorting. Note that sorting can significantly slow down the
loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined
views, but starred properties are always present no matter what the view. You can
star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

To ask the Secretary of State for Health and Social Care, what discussions his Department
has had with NICE on the prescription of medicinal cannabis oil for patients with
(a) cerebral palsy and (b) arthritis.

<p>The Department has not discussed with the National Institute for Health and Care
Excellence (NICE) the prescription of medicinal cannabis oil for patients with cerebral
palsy and arthritis.</p><p> </p><p>NICE is the independent expert body that develops
authoritative, evidence-based guidance for the National Health Service on whether
drugs and other treatments represent a clinically and cost effective use of NHS resources.
NICE is developing guidance on the prescribing of cannabis-based medicinal products
by October 2019. It will be based on the best available international evidence and
will have been produced using NICE’s world-renowned process for delivering such guidance.</p><p>
</p><p>Following a public consultation on the draft scope, the guidance will focus
on the use of cannabis-based products in the treatment of chronic pain, intractable
nausea and vomiting, spasticity and severe treatment-resistant epilepsy, conditions
where the evidence is currently most advanced. A consultation on the draft guidance
is expected in the summer.</p>

To ask the Secretary of State for Health and Social Care, what steps (a) his Department
plans to take with the NHS to respond to the findings of the Friends Families and
Travellers’ report entitled No room at the inn: How easy is it for nomadic Gypsies
and Travellers to access primary care and (b) the NHS plans to take to ensure homeless
people can access healthcare at any GP practice they choose.

<p>Registering with and access to primary medical care services is the same for all
patients, whether they are gypsies, travellers, or homeless people. People do not
need to provide proof of address to register with a general practice (GP). NHS England
is working with a range of community groups to redesign the patient registration leaflet
so that people are aware of this when registering. The free NHS 111 service can assist
anyone who has faced difficulty finding a GP or accessing other services in their
local area.</p><p> </p><p>NHS England is aware of difficulties some individuals have
faced when trying to register with a GP and is taking steps to address shortcomings
with individual practices, working in partnership with the voluntary sector.</p><p>
</p><p>The Voluntary, Community and Social Enterprise Health and Wellbeing Alliance
is a partnership arrangement with the aim to facilitate integrated working between
the voluntary and statutory sectors, to promote equality and reduce health inequalities.
It receives £1.2 million for core work from the Department, with each member receiving
funding of up to £60,000. Families and Travellers is a member of the Alliance and
have supported the Department on a range of work to date including the Inclusion Health
Audit Tool, on maternal health, mental health, end of life care and dementia.</p>

<p>Public Health England has been working with NHS England to support approaches to
obesity as part of the NHS Long Term Plan. The NHS Long Term Plan has a number of
different actions to support the drive to reduce obesity, including investment in
tier 3 services for both children and adults and plans are in development for this
expansion. This will result in, for example, a further 1,000 children a year being
treated by 2022/23 for severe complications related to obesity.</p>

<p>‘The economic burden of ill health due to diet, physical inactivity, smoking, alcohol
and obesity in the UK: an update to 2006-07 NHS costs’ estimated that overweight and
obesity cost the National Health Service in the United Kingdom £5.1 billion per year.
This figure was uplifted to £6.1 billion in 2014/15 to take account of inflation.</p><p>
</p><p>The Foresight team published ‘Tackling Obesities: Future Choices in 2007’.
This estimated the annual costs of overweight and obesity to society and the economy
as £27 billion in 2015, based on obesity prevalence at the time. In 2014 the McKinsey
Global Institute estimated the cost of obesity to the UK economy as £46 billion per
year.</p><p> </p><p>No further estimates of the costs of obesity are planned or have
been made centrally.</p><p> </p><p>Copies of ‘The economic burden of ill health due
to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to
2006-07 NHS costs’; ‘Tackling Obesities: Future Choices’; and the McKinsey Global
Institute’s report ‘Overcoming obesity: An initial economic analysis’ are available
at the following links:</p><p> </p><p><a href="https://academic.oup.com/jpubhealth/article/33/4/527/1568587"
target="_blank">https://academic.oup.com/jpubhealth/article/33/4/527/1568587</a></p><p>
</p><p><a href="https://www.gov.uk/government/publications/reducing-obesity-future-choices"
target="_blank">https://www.gov.uk/government/publications/reducing-obesity-future-choices</a></p><p>
</p><p><a href="http://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity"
target="_blank">www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity</a></p>

<p>‘The economic burden of ill health due to diet, physical inactivity, smoking, alcohol
and obesity in the UK: an update to 2006-07 NHS costs’ estimated that overweight and
obesity cost the National Health Service in the United Kingdom £5.1 billion per year.
This figure was uplifted to £6.1 billion in 2014/15 to take account of inflation.</p><p>
</p><p>The Foresight team published ‘Tackling Obesities: Future Choices in 2007’.
This estimated the annual costs of overweight and obesity to society and the economy
as £27 billion in 2015, based on obesity prevalence at the time. In 2014 the McKinsey
Global Institute estimated the cost of obesity to the UK economy as £46 billion per
year.</p><p> </p><p>No further estimates of the costs of obesity are planned or have
been made centrally.</p><p> </p><p>Copies of ‘The economic burden of ill health due
to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to
2006-07 NHS costs’; ‘Tackling Obesities: Future Choices’; and the McKinsey Global
Institute’s report ‘Overcoming obesity: An initial economic analysis’ are available
at the following links:</p><p> </p><p><a href="https://academic.oup.com/jpubhealth/article/33/4/527/1568587"
target="_blank">https://academic.oup.com/jpubhealth/article/33/4/527/1568587</a></p><p>
</p><p><a href="https://www.gov.uk/government/publications/reducing-obesity-future-choices"
target="_blank">https://www.gov.uk/government/publications/reducing-obesity-future-choices</a></p><p>
</p><p><a href="http://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity"
target="_blank">www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity</a></p>

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of
27 March 2018 to Question 133501 on obesity, for what reason his Department does not
hold information on the number of tier three obesity services commissioned by clinical
commissioning groups or local authorities; and whether he plans to collate that information.

<p>It would not be cost-effective for the Department to collect data on every clinical
intervention, including information on tier three obesity services commissioned by
clinical commissioning groups or local authorities.</p>

To ask the Secretary of State for Health and Social Care, what assessment he has made
of the implications for his policies of the conclusions of the All-Party Parliamentary
Group on Vascular and Venous Disease report entitled Saving Limbs, Saving Lives: A
Call to Action to Reduce Inequalities in Lower Limb Amputation Rates; and if he will
make a statement.

<p>The specialised commissioning Clinical Reference Group (CRG) for Vascular Disease,
together with NHS Improvement’s Getting it Right First Time (GIRFT) team, aims to
address many of the issues raised in the report. There is a joint NHS England and
GIRFT Board for the ‘Action on Vascular’ work, which is focusing on the early availability
of treatments to increase lower limb circulation and reduce amputation rates.</p><p>
</p><p>The NHS Long Term Plan published on 7 January commits to ensuring that hospitals
provide patients with access to multi-disciplinary footcare teams and inpatient specialist
nursing teams, in order to improve recovery and reduce lengths of stay and future
readmissions. This commitment will support reducing inequalities by giving universal
access to multi-disciplinary footcare teams and diabetes inpatient specialist nurses.</p>

To ask the Secretary of State for Health and Social Care, with reference to the report
from the All-Party Parliamentary Group on Vascular and Venous Disease entitled Saving
Limbs, Saving Lives: A Call to Action to Reduce Inequalities in Lower Limb Amputation
Rates, what steps he will take to address disparities in amputation rates throughout
the UK.

<p>The specialised commissioning Clinical Reference Group (CRG) for Vascular Disease,
together with NHS Improvement’s Getting it Right First Time (GIRFT) team, aims to
address many of the issues raised in the report. There is a joint NHS England and
GIRFT Board for the ‘Action on Vascular’ work, which is focusing on the early availability
of treatments to increase lower limb circulation and reduce amputation rates.</p><p>
</p><p>The NHS Long Term Plan published on 7 January commits to ensuring that hospitals
provide patients with access to multi-disciplinary footcare teams and inpatient specialist
nursing teams, in order to improve recovery and reduce lengths of stay and future
readmissions. This commitment will support reducing inequalities by giving universal
access to multi-disciplinary footcare teams and diabetes inpatient specialist nurses.</p>

<p>Experts advise that cytomegalovirus (CMV) remains difficult to diagnose because
in the majority of cases the baby presents normally at birth.</p><p> </p><p>In 2017,
the Royal College of Obstetricians and Gynaecology (RCOG) published an update for
the treatment of congenital CMV infection, acknowledging that therapeutic options
such as antiviral therapy are still being evaluated within the research setting. The
RCOG will consider whether the paper needed to be updated.</p><p> </p><p>Departmental
officials will be meeting the charity CMV Action next month to discuss their recommendations
to prevent, diagnose and intervene.</p>